Santhera Pharmaceuticals (Schweiz) AG;The United States of America as represented by The Department of Health and Human Services
发明人:
Meier, Thomas,Bielekova, Bibiana,McFarland, Henry F.
申请号：
AU2009345604
公开号：
AU2009345604B2
申请日:
2009.12.18
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The present invention relates to pharmaceuticals and uses thereof directed to the curative treating or preventing of Primary Progressive Multiple Sclerosis. (PP-MS), by using 2, 3-dιmethoxy-5-methyl-6- (10-hydroxydecyl) -1, 4-benzoquιnone (Idebenone) as the active agent.
